loading

Rapt Therapeutics Inc Azioni (RAPT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
1.40%
19.54
19.27 54.47 19.79 29.33
Depreciation and Amortization
20.63%
0.20
0.252 0.287 0.30 0.30
Operating Income/Loss
1.40%
-19.54
-19.27 -54.47 -19.79 -29.33
Nonoperating Income/Loss
9.90%
1.892
2.10 1.216 1.356 1.667
Income/Loss From Continuing Operations Before Tax
2.78%
-17.64
-17.16 -53.25 -18.43 -27.66
Income/Loss From Continuing Operations After Tax
2.78%
-17.64
-17.16 -53.25 -18.43 -27.66
Net Income/Loss
2.78%
-17.64
-17.16 -53.25 -18.43 -27.66
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
87.49%
26.95
215.41 1.9606 38.90 38.87
Diluted Average Shares
87.49%
26.95
215.41 1.9606 38.90 38.87
Basic Earnings Per Share
712.50%
-0.65
-0.08 -1.22 -0.47 -0.71
Diluted Earnings Per Share
712.50%
-0.65
-0.08 -1.22 -0.47 -0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.68
price up icon 0.59%
$84.63
price up icon 0.77%
$24.40
price down icon 9.28%
$103.63
price down icon 0.75%
$133.50
price up icon 0.97%
biotechnology ONC
$300.07
price down icon 2.83%
Capitalizzazione:     |  Volume (24 ore):